603087.SS
Price:
$66.8
Market Cap:
$39.76B
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Industry
Medical - Instruments & Supplies
IPO Date
2020-06-29
Stock Exchange
SHH
Ticker
603087.SS
According to Gan & Lee Pharmaceuticals.’s latest financial reports and current stock price. The company's current Enterprise Value is 37.71B. This represents a change of 21.24% compared to the average of 31.10B of the last 4 quarters.
The mean historical Enterprise Value of Gan & Lee Pharmaceuticals. over the last ten years is 34.15B. The current 37.71B Enterprise Value has changed 10.94% with respect to the historical average. Over the past ten years (40 quarters), 603087.SS's Enterprise Value was at its highest in in the March 2021 quarter at 70.73B. The Enterprise Value was at its lowest in in the December 2017 quarter at -790229945.00.
Average
34.15B
Median
32.38B
Minimum
15.42B
Maximum
71.43B
Discovering the peaks and valleys of Gan & Lee Pharmaceuticals. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 97.72%
Maximum Annual Enterprise Value = 71.43B
Minimum Annual Increase = -57.42%
Minimum Annual Enterprise Value = 15.42B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 25.16B | -8.17% |
| 2023 | 27.40B | 77.71% |
| 2022 | 15.42B | -57.42% |
| 2021 | 36.21B | -49.30% |
| 2020 | 71.43B | 97.72% |
| 2019 | 36.13B | 11.77% |
| 2018 | 32.32B | 0.56% |
| 2017 | 32.14B | -0.93% |
| 2016 | 32.45B | -1.29% |
| 2015 | 32.87B | 1.09% |
The current Enterprise Value of Gan & Lee Pharmaceuticals. (603087.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.66B
5-year avg
35.13B
10-year avg
34.15B
Gan & Lee Pharmaceuticals.’s Enterprise Value is greater than Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (29.88B), greater than APT Medical Inc. (35.63B), less than Imeik Technology Development Co.,Ltd. (41.66B), greater than Changchun High-Tech Industries (Group) Inc. (37.02B), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (48.80B), greater than Beijing Tiantan Biological Products Co., Ltd. (30.58B), greater than Hangzhou Tigermed Consulting Co., Ltd. (37.07B), less than Beijing Tongrentang Co., Ltd (38.41B), greater than iRay Technology Company Limited (19.88B), greater than Shanghai Junshi Biosciences Co., Ltd. (36.51B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 29.88B | $36.62B | |
| 35.63B | $36.60B | |
| 41.66B | $42.80B | |
| 37.02B | $38.29B | |
| 48.80B | $41.72B | |
| 30.58B | $32.25B | |
| 37.07B | $36.97B | |
| 38.41B | $44.67B | |
| 19.88B | $19.47B | |
| 36.51B | $35.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gan & Lee Pharmaceuticals. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gan & Lee Pharmaceuticals. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Gan & Lee Pharmaceuticals.'s Enterprise Value?
What is the highest Enterprise Value for Gan & Lee Pharmaceuticals. (603087.SS)?
What is the 3-year average Enterprise Value for Gan & Lee Pharmaceuticals. (603087.SS)?
What is the 5-year average Enterprise Value for Gan & Lee Pharmaceuticals. (603087.SS)?
How does the current Enterprise Value for Gan & Lee Pharmaceuticals. (603087.SS) compare to its historical average?